Table 4. Effect of CGM data on postoperative morbidity.

	POAF (+)	POAF (−)	p value	Analysis	SSI (+)	SSI (−)	p value	Analysis
	(n = 8)	(n = 11)			(n = 5)	(n = 71)
Preoperative
Mean (mg/dL)	123.9 ± 15.8	110.5 ± 25.5	0.18	MHU	121.3 ± 22.1	106.1 ± 18.9	0.09	MHU
SD (mg/dL)	26.7 ± 8.2	24.3 ± 9.0	0.49	MHU	25.6 ± 16.9	20.9 ± 7.5	0.55	MHU
Max (mg/dL)	207.4 ± 33.3	175.5 ± 39.8	0.08	MHU	200.6 ± 67.8	166.1 ± 35.3	0.20	MHU
Min (mg/dL)	82.0 ± 22.9	63.3 ± 17.7	0.051	MHU	72.2 ± 20.3	67.6 ± 15.8	0.49	MHU
Intraoperative
Mean (mg/dL)	124.3 ± 19.4	115.4 ± 19.3	0.49	MHU	170.3 ± 51.8	142.1 ± 34.5	0.19	MHU
SD (mg/dL)	9.1 ± 4.6	8.6 ± 4.7	0.54	MHU	43.2 ± 21.5	28.0 ± 20.5	0.12	MHU
Max (mg/dL)	146.0 ± 38.1	129.3 ± 20.8	0.34	MHU	232.2 ± 64.8	188.5 ± 63.4	0.11	MHU
Min (mg/dL)	106.4 ± 14.1	98.2 ± 22.7	0.30	MHU	101.2 ± 21.4	96.4 ± 21.2	0.53	MHU
CIII period
Mean (mg/dL)	127.7 ± 7.3	126.6 ± 9.0	0.53	MHU	131.5 ± 3.8	127.2 ± 8.4	0.20	MHU
SD (mg/dL)	20.3 ± 9.3	15.8 ± 6.4	0.30	MHU	21.6 ± 9.8	19.3 ± 8.0	0.51	MHU
Max (mg/dL)	175.3 ± 31.2	162.6 ± 18.0	0.53	MHU	199.8 ± 49.3	177.7 ± 28.7	0.29	MHU
Min (mg/dL)	87.5 ± 17.2	92.9 ± 12.3	0.52	MHU	95.0 ± 16.4	90.4 ± 12.2	0.50	MHU
SQII period
Mean (mg/dL)	160.1 ± 35.8	144.3 ± 18.3	0.24	MHU	170.3 ± 36.5	139.2 ± 22.9	0.01*	MHU
SD (mg/dL)	45.2 ± 22.4	25.3 ± 9.1	0.048*	MHU	41.0 ± 16.2	27.9 ± 16.1	0.04*	MHU
Max (mg/dL)	284.9 ± 80.8	214.6 ± 32.0	0.02*	MHU	280.8 ± 68.2	215.4 ± 61.3	0.02*	MHU
Min (mg/dL)	81.1 ± 17.9	97.7 ± 16.1	0.08	MHU	99.6 ± 11.4	88.4 ± 17.6	0.19	MHU

^*Value is statistically significant. CGM: continuous glucose monitoring; SSI: surgical site infection; POAF: postoperative atrial fibrillation; MHU: Mann–Whitney U-test; SD: standard deviation; CIII: continuous intravenous insulin infusion; SQII: subcutaneous insulin infusion